Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III.
By P. Greenland, J. Abrams, G. Aurigemma, M. Bond, L. Clark, M. Criqui, J. R. Crouse, L. Friedman, Valentin Fuster, D. Herrington and 8 more. Circulation, 2000
921 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Public Health, Environmental and Occupational Health
View Paper: https://www.semanticscholar.org/paper/5ef73c08cc15a18f8f1283448a6d509011136895
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
In Public Health, Environmental and Occupational Health
Citations in the corpus
- European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) (2012, positive): “Total risk estimation using multiple risk factors (such as SCORE) is recommended for asymptomatic adults without evidence of CVD.”
- Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. (2008, background): “To prevent death and morbidity from CVD, there is great interest in identifying asymptomatic patients at high risk who would be candidates for more intensive, evidence-based medical interventions that reduce CVD risk.(3,4) Imaging of arteries to identify and quantify the presence of subclinical vasc”